“The greatest danger of another catastrophic attack in the United States will materialize if the world's most dangerous terrorists acquire the world's most dangerous weapons.” —The 9/11 Commission Report
The bipartisan Commission on the Prevention of Weapons of Mass Destruction Proliferation and Terrorism was established by the U.S. Congress to build on the work of the 9/11 Commission by assessing our nation's progress in preventing weapons of mass destruction proliferation and terrorism, and providing a roadmap to greater security with concrete recommendations for improvement.
The Commission has interviewed over 200 experts inside and outside of government. They have met with counterterrorism and intelligence officials here at home and abroad who are working to stop proliferation and terrorism The Commission's report examines the government's current policies and programs, identifies gaps in our government's prevention strategy and recommends ways to close them.
The threat of terrorist attacks in the United States and elsewhere is still very real. The world remians at risk There is more that can and must be done. Our security depends on it.
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
Established by House Resolution 1 in May 2008, the Commission on the Prevention of Weapons of Mass Destruction Proliferation and Terrorism was chaired by former Senator Bob Graham. Members of this bi-partisan committee included Vice-Chairman Jim Talent, Timothy J. Roemer, Wendy R. Sherman, Graham T. Allison, Richard Verma, Henry Sokolski, Stephen Rademaker, and Robin Cleveland.
Bob Graham is a retired US Senator, who served three terms representing Florida. While recognized for his leadership on issues ranging from health care to environmental preservation, Senator Graham is best known for his 10 years of service on the Senate Select Committee on Intelligence, including 18 months as chairman in 2001–2002, during which he cochaired the House-Senate Joint Inquiry into the intelligence community’s failures prior to 9/11. Following the release of a declassified version of the Joint Inquiry’s final report in July 2003, Senator Graham advocated reform of the intelligence community and sponsored legislation to bring about needed changes.
Biological Risks
They were agents on a mission and they came not at night, which might have looked suspicious, but in broad daylight. Hiding in plain sight on a city street in Atlanta, they walked the perimeter of one of America's five biological laboratories where scientists worked on the world's most deadly pathogens. They had come to this lab at Georgia State University in 2008 as part of their assignment to quietly case facilities designated as Biosafety Level 4 (BSL-4) labs, the highest level of biological containment, required for work with the most dangerous viruses. They were looking for even the slightest security vulnerability--anything that might give an edge to terrorists seeking to steal small quantities of Ebola virus or other lethal disease agents for which there are no treatments, no known cures.
These individuals discovered that in a number of places, the lab was unprotected by barriers and that outsiders could walk right up to the building housing these deadly pathogens. Around back, they watched and took notes as a pedestrian simply strolled into the building through an unguarded loading dock.
On another day, the same people went to San Antonio to check out another BSL-4 lab, the Southwest Foundation for Biomedical Research. They discovered that the security camera covered only a portion of the perimeter, and that the only barrier to vehicles was an arm gate that would swing across the roadway. The guards assigned to protect this facility were unarmed. Once again, these individuals walked the perimeter. This time they spotted a window through which, standing outside, they could watch the scientists as they worked with top-security pathogens. Now they knew exactly where the world's most deadly pathogens were kept.
This was precisely the lethal trove that al Qaeda's terrorists had been seeking for years. But luckily, these operatives on this mission were not from al Qaeda--they were from the Government Accountability Office (GAO), the investigative arm of the U.S. Congress, and they visited five of America's labs that are designated BSL-4. For more than a decade, U.S. government inspection teams have traveled to facilities in the former Soviet Union and reported back on the poor security and lax practices used in storing biological pathogens. Now, this latest study by GAO has shown that when it comes to materials of bioterrorism, America's vulnerability may well begin at home.
The GAO report gave high marks to three of the five facilities investigated. The investigators measured how the labs fared in 15 security control categories, and these labs met the standards for, respectively, 13, 14, and all 15. Among the 15 security controls were having armed security guards visible at all public entrances to the lab, full camera coverage of all exterior entrances, and closed-circuit television and a command and control center so that any security breach could be instantly known throughout the facility.
But the two lowest-scoring BSL-4 labs passed in only 3 and 4 of the 15 categories--a score that is even more troubling because, as GAO noted, both still met the requirements of the Division of Select Agents and Toxins of the Centers for Disease Control and Prevention (CDC).
Despite these shortcomings, the United States is actually at the forefront of laboratory security in the world today and has by far the most stringent regulations to restrict access to dangerous pathogens. Most developing countries, in contrast, have largely ignored the problem of biosecurity because of competing demands for their limited budgets. Security gaps at laboratories that store and work with dangerous pathogens, both in the United States and around the world, are worrisome because of continued interest in biological weapons. Director of National Intelligence Michael McConnell said in a recent speech, "One of our greatest concerns continues to be that a terrorist group or some other dangerous group might acquire and employ biological agents . . . to create casualties greater than September 11."
Al Qaeda has long sought to obtain biological and chemical weapons. One of its leading experts in the quest for such weapons was Midhat Mursi al-Sayid Umar, an Egyptian also known as Abu Khabab al-Masri. According to media accounts, he was killed in July 2008 by an airstrike over Pakistan's northern tribal area.
On July 17, 2008, the Afghanistan National Police arrested Aafia Siddiqui, a Pakistani woman believed to have ties to al Qaeda, who reportedly had been acting suspiciously outside the governor's compound in Ghazni province. Educated at the Massachusetts Institute of Technology and at Brandeis University, where she earned a Ph.D. in neuroscience, she had been wanted by the FBI since 2004--the first woman sought by the law enforcement agency in connection with al Qaeda. According to media accounts, when arrested she had in her possession a list of New York City landmarks, documents describing how to produce explosives, and details about chemical, biological, and radiological weapons. She was extradited to New York for trial on charges of attempted murder and assault of U.S. officers in Afghanistan.
The world is fortunate that al Qaeda to date is not known to have successfully stolen, bought, or developed agents of bioterror. But scenarios of just how such an incident might occur have been developed for planning purposes. The Homeland Security Council has created a chilling scenario of how terrorists could launch an anthrax attack in the United States--and the horrific chain of events that would follow:
This scenario describes a single aerosol [anthrax] attack in one city delivered by a truck using a concealed improvised spraying device in a densely populated urban city with a significant commuter workforce. It does not, however, exclude the possibility of multiple attacks in disparate cities or time-phased attacks (i.e., "reload"). For federal planning purposes, it will be assumed that the Universal Adversary (UA) will attack five separate metropolitan areas in a sequential manner. Three cities will be attacked initially, followed by two additional cities 2 weeks later.
It is possible that a Bio-Watch [atmospheric sensor] signal would be received and processed, but this is not likely to occur until the day after the release. The first cases of anthrax would begin to present to Emergency Rooms (ERs) approximately 36 hours post-release, with rapid progression of symptoms and fatalities in untreated (or inappropriately treated) patients.
The situation in the hospitals will be complicated by the following facts: The release has occurred at the beginning of an unusually early influenza season and the prodromal [early] symptoms of inhalation anthrax are relatively non-specific. Physician uncertainty will result in low thresholds for admission and administration of available countermeasures (e.g., antibiotics), producing severe strains on commercially available supplies of medications such as ciprofloxacin and doxycycline, and exacerbating the surge capacity problem.
Social order questions will arise. The public will want to know very quickly if it is safe to remain in the affected city and surrounding regions. Many persons will flee regardless of the public health guidance that is provided. Pressure may be placed directly on pharmacies to dispense medical countermeasures directly, and it will be necessary to provide public health guidance in more than a dozen languages.
The attack results in 328,848 exposures; 13,208 untreated fatalities; and 13,342 total casualties. Although property damage will be minimal, city services will be hampered by safety concerns.
In September 2001, an American public already reeling from the worst terrorist attack in U.S. history was stunned by news that envelopes containing anthrax had been delivered via the...
„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.
Anbieter: BooksRun, Philadelphia, PA, USA
Paperback. Zustand: Good. Authorized ed. It's a preowned item in good condition and includes all the pages. It may have some general signs of wear and tear, such as markings, highlighting, slight damage to the cover, minimal wear to the binding, etc., but they will not affect the overall reading experience. Artikel-Nr. 0307473260-11-1
Anzahl: 1 verfügbar
Anbieter: Wonder Book, Frederick, MD, USA
Zustand: Very Good. Very Good condition. A copy that may have a few cosmetic defects. May also contain light spine creasing or a few markings such as an owner's name, short gifter's inscription or light stamp. Artikel-Nr. A09J-00376
Anzahl: 2 verfügbar
Anbieter: ThriftBooks-Dallas, Dallas, TX, USA
Paperback. Zustand: Very Good. No Jacket. May have limited writing in cover pages. Pages are unmarked. ~ ThriftBooks: Read More, Spend Less. Artikel-Nr. G0307473260I4N00
Anzahl: 1 verfügbar
Anbieter: Better World Books, Mishawaka, IN, USA
Zustand: Fine. Used book that is in almost brand-new condition. Artikel-Nr. 16384630-75
Anzahl: 1 verfügbar
Anbieter: medimops, Berlin, Deutschland
Zustand: good. Befriedigend/Good: Durchschnittlich erhaltenes Buch bzw. Schutzumschlag mit Gebrauchsspuren, aber vollständigen Seiten. / Describes the average WORN book or dust jacket that has all the pages present. Artikel-Nr. M00307473260-G
Anzahl: 1 verfügbar
Anbieter: Kennys Bookstore, Olney, MD, USA
Zustand: New. 2008. Authorized ed. Paperback. . . . . . Books ship from the US and Ireland. Artikel-Nr. V9780307473264
Anzahl: 15 verfügbar
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
Paperback. Zustand: Brand New. 11.3.2008 edition. 132 pages. 7.80x5.10x0.80 inches. In Stock. Artikel-Nr. 0307473260
Anzahl: 1 verfügbar